Your session is about to expire
← Back to Search
Exercise Induced Hypoalgesia Diabetes (EIHDM Trial)
N/A
Waitlist Available
Led By Marlon L. Wong, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 20 minutes
Awards & highlights
No Placebo-Only Group
Summary
The purpose of this research study is to learn whether different forms of exercise can reduce pain experienced by individuals with painful diabetic peripheral neuropathy.
Eligible Conditions
- Diabetic Neuropathy
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 20 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 20 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Pain Pressure Threshold (PPT)
Secondary study objectives
Change in Heat Pain Threshold (HPT)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Cycling at a Moderate Intensity Aerobic Exercise (AE) groupExperimental Treatment1 Intervention
All participants will be asked to cycle during the first phase at a moderate intensity for 20 minutes.
Group II: Blood Flow restriction training with cycling at a moderate intensity (BFR+AE) groupExperimental Treatment2 Interventions
All participants will be asked to wear an automated personalize tourniquet system to restrict blood flow. Participants will be asked to lie in supine and a non-shedding stockinette protection sleeve will be placed at bilateral proximal thighs. Then, participants will be asked to cycle at a moderate intensity for 20 minutes during the second phase.
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
955 Previous Clinical Trials
428,848 Total Patients Enrolled
Marlon L. Wong, PhDPrincipal InvestigatorUniversity of Miami